A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

Eczema can be very challenging to deal with, especially in the winter. The cold, dry air can exacerbate symptoms, leading to ...

Living with eczema is more than just occasional flare-ups. It’s an ongoing struggle with relentless itching, redness, and ...

KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...

Kyle has had moderate to severe eczema across most of his body since he was an infant. Throughout his life, he’s faced a mix ...

AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...

The Albanese Government has ensured thousands of Australians living with severe eczema will continue to have access to ...

When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.

Switzerland’s Galderma has won US Food and Drug Administration (FDA) approval for the use of Nemluvio (nemolizumab) for ...

Researchers believe they’ve discovered the hidden culprit behind eczema itch, paving the way for groundbreaking new treatment ...

Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record ...

Health Minister Mark Butler has struck a deal to secure the place of a “life-changing” eczema treatment on the Pharmaceutical ...